Patents Assigned to Beiging Weifeng Yimin Bio-Technology Limited Company
  • Use of Rupatadine in the Manufacture of Pharmaceutical Composition for Treating Chronic Obstructive Pulmonary Disease
    Publication number: 20150018382
    Abstract: Disclosed is the use of rupatadine in the manufacture of pharmaceutical composition for preventing or treating chronic obstructive bronchitis, obstructive emphysema or chronic obstructive pulmonary disease. The new medicament, i.e. rupatadine, for treating chronic obstructive pulmonary disease is obvious in therapeutic effects, and low in toxic and side effects, and safe in use in the aspects of treating chronic obstructive bronchitis, obstructive emphysema or chronic obstructive pulmonary disease.
    Type: Application
    Filed: May 18, 2012
    Publication date: January 15, 2015
    Applicant: Beiging Weifeng Yimin Bio-Technology Limited Company
    Inventor: Zhuowei Hu